NCT03866642

Two Year Follow up of Cadence Total Ankle Replacement

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: Unity Health Toronto · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Over the last decades, total ankle replacement (TAR) emerged as a reliable treatment option in end-stage ankle osteoarthritis (OA) while preserving motion and physiological load. The Cadence™ is a fourth-generation, two-component, fixed-bearing implant with minimal tibial and talar resection. It has been in clinical use since July 2016, the purpose of this study was to compare the clinical outcome and radiological outcomes of total ankle arthroplasty with use of the Cadence™ prosthesis at St. Michael's Hospital.

Detailed description

Over the last decades, total ankle replacement (TAR) emerged as a reliable treatment option in end-stage ankle osteoarthritis (OA) while preserving motion and physiological load. The Cadence™ is a fourth-generation, two-component, fixed-bearing implant with minimal tibial and talar resection. It has been in clinical use since July 2016, the purpose of this study was to compare the clinical outcome and radiological outcomes of total ankle arthroplasty with use of the Cadence™ prosthesis at St. Michael's Hospital.

Conditions

• Ankle Arthritis

Interventions

Type	Name	Description
DEVICE	Cadence Total Ankle Replacment	Cadence Total Ankle prosthesis

Timeline

• Start date: 2018-09-01
• Primary completion: 2019-01-05
• Completion: 2019-07-01
• First posted: 2019-03-07
• Last updated: 2019-03-07

Locations

1 site across 1 country: Canada

Regulatory

• FDA-regulated device study